Health

FDA Findings Show Yet Another Impurity In Heart Drug Valsartan

FDA Findings Show Yet Another Impurity In Heart Drug Valsartan

A photo of a man getting blood pressure tested. The FDA has found NDEA, another known carcinogen, in some batches of valsartan drugs used for treating heart conditions and high blood pressure.   ( Gerald Oswald | Pixabay )

The U.S. Food and Drug Administration has found more “unexpected impurity” in several pills that contain the recalled valsartan drug.

Valsartan is a common ingredient in medication for people who experience high blood pressure and heart failure. However, in July, it has been recalled because public health officials found that it is tainted with N-nitrosodimethylamine or NDMA, an organic chemical used to make rocket fuel and a by-product from manufacturing pesticides. It is also a suspected carcinogen.

In a press release published and disseminated on Thursday, Sept. 13, the FDA told the public about the results of an ongoing investigation around valsartan.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.